Screener
Design Therapeutics, Inc. DSGN Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026. Open the filing →
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
FAQ
- What is Design Therapeutics, Inc.'s debt-to-equity?
- Design Therapeutics, Inc. (DSGN) reported debt-to-equity of 0× in Q1 2026.
- How has Design Therapeutics, Inc.'s debt-to-equity changed year-over-year?
- Design Therapeutics, Inc.'s debt-to-equity increased by 33.0% year-over-year, from 0× to 0×.
- What is the long-term trend for Design Therapeutics, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s debt-to-equity has grown at a -6.7% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Design Therapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude